AstraZeneca buys most of Acerta for $4 billion to add cancer drug
LONDON AstraZeneca (AZN.L) said on Thursday it had agreed to buy 55 percent stake of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of drug for fighting blood cancers. AstraZeneca will pay $2.5 billion upfront, with a ... More »
